{"id":685039,"date":"2022-09-14T07:27:22","date_gmt":"2022-09-14T11:27:22","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\/"},"modified":"2022-09-14T07:27:22","modified_gmt":"2022-09-14T11:27:22","slug":"first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\/","title":{"rendered":"First Wave BioPharma CEO James Sapirstein to Moderate Panel Discussion at Longwood Healthcare Leaders Fall Webconference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">BOCA RATON, Fla., Sept.  14, 2022  (GLOBE NEWSWIRE) &#8212; First Wave BioPharma, Inc., (NASDAQ: FWBI), (\u201cFirst Wave BioPharma\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for\u00a0gastrointestinal (GI) diseases, today announced that James Sapirstein, Chairman, President, and CEO of First Wave BioPharma, will moderate a panel discussion on drug development during the Longwood Healthcare Leaders Fall Webconference taking place September 21-22, 2022.<\/p>\n<p align=\"justify\">The panel, titled, \u201cAccelerating Drug Development,\u201d will include Christian Antoni, Chief Development Officer, EQRx; Matt Gevaert, CEO, Kiyatec; Priya Singhal, Interim Head of R&amp;D, SVP, Global Head, Safety &amp; Regulatory Sciences, Biogen; and Pamela Stetkiewicz, Chief Operating Officer, Arbor Biotechnologies.<\/p>\n<p align=\"justify\">Details of the panel discussion are as follows:<\/p>\n<table style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">\n            <strong>Event:<\/strong>\n          <\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">Longwood Healthcare Leaders Fall Webconference<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">\n            <strong>Panel:<\/strong>\n          <\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">Accelerating Drug Development<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">\n            <strong>Date:<\/strong>\n          <\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">Thursday, September 22, 2022<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">\n            <strong>Time:<\/strong>\n          <\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">8:50 am, ET<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">\n            <strong>Location:<\/strong>\n          <\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">\n            <a href=\"http:\/\/www.longwoodhealthcareleaders.com\" rel=\"nofollow noopener\" target=\"_blank\">www.longwoodhealthcareleaders.com<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">\n        <strong>About First Wave BioPharma, Inc.<\/strong><br \/>\n        <br \/>First Wave BioPharma is a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The Company is currently advancing a therapeutic development pipeline with multiple clinical stage programs built around its two proprietary technologies \u2013 the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients, and niclosamide, an oral small molecule with anti-inflammatory properties. First Wave is advancing two Phase 2 clinical programs built around adrulipase for the treatment of exocrine pancreatic insufficiency (FW-EPI) in patients with cystic fibrosis (CF) and chronic pancreatitis (CP). In developing adrulipase, First Wave is seeking to provide CF and CP patients with a safe and effective therapy to control EPI that is non-animal derived and offers the potential to dramatically reduce their daily pill burden. The company is also advancing multiple programs involving niclosamide, including FW-UP for ulcerative proctitis and ulcerative proctosigmoiditis, FW-UC for ulcerative colitis, and FW-CD for Crohn\u2019s disease. First Wave BioPharma is headquartered in Boca Raton, Florida. For more information visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=H7hXLdV6e23AHpZE6SZu89pEJv3FkS974hu1QF7HFKheLfZAXniiWiEI9zG9GMPfLis9m88Z5im-43tYedgvtMAb7kqglygz_K8FYGpdeko=\" rel=\"nofollow noopener\" target=\"_blank\">www.firstwavebio.com<\/a>.<\/p>\n<p>\n        <strong>About Longwood Healthcare Leaders: <\/strong><br \/>\n        <br \/>Longwood Healthcare Leaders meetings bring together leading biotech and pharma CEOs, heads of R&amp;D, top academics, and healthcare investors for off-the-record discussions to drive transparency and collaboration in order to accelerate the translation of discoveries into medicines to help patients. Substantial donations enabled by these meetings benefit several charities. To learn more about the event, view the agenda, and request an invitation, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=48AUX5nPut4nQ9RDq3vEIH2dzsvMueEiZRG-vV4VGND8CHSM7GtAnjKfeR4H6rq_T60Xbh2V4XCvURHsW3E80DA3o_V463EQ5l7Yg6jKfxKuw3P8nY_Vl7SRbxyYcaJB\" rel=\"nofollow noopener\" target=\"_blank\">www.longwoodhealthcareleaders.com<\/a>. Meetings are invitation-only.<\/p>\n<p align=\"justify\">\n        <strong>For more information:<\/strong><br \/>\n        <br \/>First Wave BioPharma, Inc.<br \/>777 Yamato Road, Suite 502<br \/>Boca Raton, FL 33431<br \/>Phone: (561) 589-7020<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Vb2ZuKm2PaV_QlQZOwwSb0yfKyte8tFEU1151fRQ-Fh5LWtCmfRzq-zzO9jL2Qv_tTtTbreHOw0sAQ1glsoZVo1xIX6X9tpVznJTNGe4Tdw=\" rel=\"nofollow noopener\" target=\"_blank\">info@firstwavebio.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>Media contact:<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AAc9TeQlNE4PGCZPkx04S3jf3P144gQtlvsDYSl-s2-eZIduXwkbTcDt033wTCiK4C0tqn34CFSieISThBLhUt-hLcQacLO9nJZNokRLFx4=\" rel=\"nofollow noopener\" target=\"_blank\">Tiberend Strategic Advisors, Inc.<\/a><br \/>\n        <br \/>David Schemelia<br \/>(609) 468-9325 <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=l3-wC3m9k6Ev8L9BLEYxhStmPmzLCot1OQpEBGC7sG-eC9lywobvznsI1lUtDlhgcw1vDcDaYmWUXHi3RkaK-N7WCWgmiqsdhFyjDo0P-nw=\" rel=\"nofollow noopener\" target=\"_blank\">dschemelia@tiberend.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0MjU5NyM1MTQxMzkyIzIwODIyMDc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YTRmNDFkYmEtM2ZjNy00YzI0LTk4OGItZTg3Njk2ZWM1YjAyLTEwOTM3Nzg=\/tiny\/First-Wave-BioPharma-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOCA RATON, Fla., Sept. 14, 2022 (GLOBE NEWSWIRE) &#8212; First Wave BioPharma, Inc., (NASDAQ: FWBI), (\u201cFirst Wave BioPharma\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for\u00a0gastrointestinal (GI) diseases, today announced that James Sapirstein, Chairman, President, and CEO of First Wave BioPharma, will moderate a panel discussion on drug development during the Longwood Healthcare Leaders Fall Webconference taking place September 21-22, 2022. The panel, titled, \u201cAccelerating Drug Development,\u201d will include Christian Antoni, Chief Development Officer, EQRx; Matt Gevaert, CEO, Kiyatec; Priya Singhal, Interim Head of R&amp;D, SVP, Global Head, Safety &amp; Regulatory Sciences, Biogen; and Pamela Stetkiewicz, Chief Operating Officer, Arbor Biotechnologies. Details of the panel discussion are as follows: Event: Longwood Healthcare &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;First Wave BioPharma CEO James Sapirstein to Moderate Panel Discussion at Longwood Healthcare Leaders Fall Webconference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-685039","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>First Wave BioPharma CEO James Sapirstein to Moderate Panel Discussion at Longwood Healthcare Leaders Fall Webconference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"First Wave BioPharma CEO James Sapirstein to Moderate Panel Discussion at Longwood Healthcare Leaders Fall Webconference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOCA RATON, Fla., Sept. 14, 2022 (GLOBE NEWSWIRE) &#8212; First Wave BioPharma, Inc., (NASDAQ: FWBI), (\u201cFirst Wave BioPharma\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for\u00a0gastrointestinal (GI) diseases, today announced that James Sapirstein, Chairman, President, and CEO of First Wave BioPharma, will moderate a panel discussion on drug development during the Longwood Healthcare Leaders Fall Webconference taking place September 21-22, 2022. The panel, titled, \u201cAccelerating Drug Development,\u201d will include Christian Antoni, Chief Development Officer, EQRx; Matt Gevaert, CEO, Kiyatec; Priya Singhal, Interim Head of R&amp;D, SVP, Global Head, Safety &amp; Regulatory Sciences, Biogen; and Pamela Stetkiewicz, Chief Operating Officer, Arbor Biotechnologies. Details of the panel discussion are as follows: Event: Longwood Healthcare &hellip; Continue reading &quot;First Wave BioPharma CEO James Sapirstein to Moderate Panel Discussion at Longwood Healthcare Leaders Fall Webconference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-14T11:27:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0MjU5NyM1MTQxMzkyIzIwODIyMDc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"First Wave BioPharma CEO James Sapirstein to Moderate Panel Discussion at Longwood Healthcare Leaders Fall Webconference\",\"datePublished\":\"2022-09-14T11:27:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\\\/\"},\"wordCount\":438,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY0MjU5NyM1MTQxMzkyIzIwODIyMDc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\\\/\",\"name\":\"First Wave BioPharma CEO James Sapirstein to Moderate Panel Discussion at Longwood Healthcare Leaders Fall Webconference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY0MjU5NyM1MTQxMzkyIzIwODIyMDc=\",\"datePublished\":\"2022-09-14T11:27:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY0MjU5NyM1MTQxMzkyIzIwODIyMDc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY0MjU5NyM1MTQxMzkyIzIwODIyMDc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"First Wave BioPharma CEO James Sapirstein to Moderate Panel Discussion at Longwood Healthcare Leaders Fall Webconference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"First Wave BioPharma CEO James Sapirstein to Moderate Panel Discussion at Longwood Healthcare Leaders Fall Webconference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\/","og_locale":"en_US","og_type":"article","og_title":"First Wave BioPharma CEO James Sapirstein to Moderate Panel Discussion at Longwood Healthcare Leaders Fall Webconference - Market Newsdesk","og_description":"BOCA RATON, Fla., Sept. 14, 2022 (GLOBE NEWSWIRE) &#8212; First Wave BioPharma, Inc., (NASDAQ: FWBI), (\u201cFirst Wave BioPharma\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for\u00a0gastrointestinal (GI) diseases, today announced that James Sapirstein, Chairman, President, and CEO of First Wave BioPharma, will moderate a panel discussion on drug development during the Longwood Healthcare Leaders Fall Webconference taking place September 21-22, 2022. The panel, titled, \u201cAccelerating Drug Development,\u201d will include Christian Antoni, Chief Development Officer, EQRx; Matt Gevaert, CEO, Kiyatec; Priya Singhal, Interim Head of R&amp;D, SVP, Global Head, Safety &amp; Regulatory Sciences, Biogen; and Pamela Stetkiewicz, Chief Operating Officer, Arbor Biotechnologies. Details of the panel discussion are as follows: Event: Longwood Healthcare &hellip; Continue reading \"First Wave BioPharma CEO James Sapirstein to Moderate Panel Discussion at Longwood Healthcare Leaders Fall Webconference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\/","og_site_name":"Market Newsdesk","article_published_time":"2022-09-14T11:27:22+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0MjU5NyM1MTQxMzkyIzIwODIyMDc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"First Wave BioPharma CEO James Sapirstein to Moderate Panel Discussion at Longwood Healthcare Leaders Fall Webconference","datePublished":"2022-09-14T11:27:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\/"},"wordCount":438,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0MjU5NyM1MTQxMzkyIzIwODIyMDc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\/","name":"First Wave BioPharma CEO James Sapirstein to Moderate Panel Discussion at Longwood Healthcare Leaders Fall Webconference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0MjU5NyM1MTQxMzkyIzIwODIyMDc=","datePublished":"2022-09-14T11:27:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0MjU5NyM1MTQxMzkyIzIwODIyMDc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0MjU5NyM1MTQxMzkyIzIwODIyMDc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-wave-biopharma-ceo-james-sapirstein-to-moderate-panel-discussion-at-longwood-healthcare-leaders-fall-webconference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"First Wave BioPharma CEO James Sapirstein to Moderate Panel Discussion at Longwood Healthcare Leaders Fall Webconference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/685039","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=685039"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/685039\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=685039"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=685039"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=685039"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}